ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Servier
AstraZeneca
Myeloid Therapeutics
Amgen
DualityBio Inc.
Boehringer Ingelheim
NextCure, Inc.
Tanabe Pharma America, Inc.
AstraZeneca
Bayer
Eli Lilly and Company
Merck Sharp & Dohme LLC
Bolt Biotherapeutics, Inc.
Yuhan Corporation
Bristol-Myers Squibb
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
Evopoint Biosciences Inc.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Zumutor Biologics Inc.
Vincerx Pharma, Inc.
Taiho Pharmaceutical Co., Ltd.
Eli Lilly and Company
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Cantargia AB
Ambrx, Inc.
Silverback Therapeutics
AstraZeneca